Japanese biopharmaceutical company Takeda has committed up to USD30 million, or around Rp539 billion, to develop Indonesia’s plasma-derived medicines product ecosystem through the establishment of a plasma bank network over two years (10/07).

The Ministry of Investment and Downstreaming/Investment Coordinating Board (BKPM) welcomed the investment commitment as part of efforts to develop Indonesia’s national plasma industry foundation.

Japan’s Takeda Commits Investment for Indonesia Plasma Product Ecosystem

Takeda’s initial investment will focus on building a plasma bank network as the foundation for developing the plasma-derived products (PODP) industry in Indonesia.

Investment Minister and Head of BKPM Rosan P. Roeslani said the investment reflects stronger global investor confidence in Indonesia’s prospects, especially in high-technology healthcare industries.

"Investasi ini merupakan investasi strategis yang tidak hanya menghadirkan tambahan modal, tetapi juga membuka peluang transfer teknologi, pengembangan sumber daya manusia, serta penciptaan lapangan kerja berketerampilan tinggi. Pemerintah terus mendorong investasi yang memberikan nilai tambah dan memperkuat kapasitas industri nasional sehingga Indonesia dapat menjadi pusat manufaktur dan inovasi kesehatan di kawasan," ujar Menteri Rosan.

Rosan said the investment is a strategic investment that provides additional capital while creating opportunities for technology transfer, human resource development, and high-skilled job creation.

Investment Supports Healthcare Technology Transfer and Industrial Development

The partnership is aligned with Indonesia’s economic transformation agenda through downstreaming in strategic sectors, including healthcare.

The government continues to encourage investments that provide added value and strengthen national industrial capacity to support Indonesia as a manufacturing and healthcare innovation center in the region.

Indonesia-Japan Healthcare Investment Cooperation Strengthens

Japan is one of Indonesia’s strategic investment partners. Based on data from the Ministry of Investment and Downstreaming/BKPM, Japan ranked fifth among Indonesia’s main investors in the first quarter of 2026, with investment reaching USD1 billion.

Japan’s total realized investment in Indonesia from 2021 to the first quarter of 2026 reached USD18.1 billion, with average growth of 13.2% and employment absorption reaching 299,460 people.

The government said this investment record provides a strong foundation for expanding cooperation in various priority sectors, including healthcare.

First Plasma Bank Targeted to Operate in 2027

Through the collaboration with Takeda, the Indonesian government expects the country to improve public access to plasma-derived medicines while developing a competitive, innovative, and sustainable biopharmaceutical industry ecosystem.

The first plasma bank is targeted to begin operations in 2027 as part of the development of a national plasma network that meets international standards.

PHOTO: TAKEDA

This article was created with AI assistance.

We make every effort to ensure the accuracy of our content, some information may be incorrect or outdated. Please let us know of any corrections at [email protected].